Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menthyl valerate is an ester formed from menthol and valeric acid. It is a colorless to pale yellow oily liquid with a characteristic odor of menthol and valerian. Menthyl valerate is used primarily as a flavoring agent in the food industry and as an active ingredient in certain anxiolytic medications—most notably under the brand name Validol. In pharmaceutical use (especially in Eastern Europe), it is often combined with free menthol (about 25–30%) to form sublingual tablets or lozenges for relief of nervous tension, anxiety, functional cardialgias (chest pain not related to heart disease), neuroses, and as an antiemetic for motion sickness[4][5][6][7][8][9]. The mechanism of action appears to involve mild sedative effects through positive allosteric modulation of GABAA receptors[5], leading to anxiolytic and calming properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on menthyl valerate.